Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thymus Neoplasms 1 Shoulder Disease 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Margins of Excision 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hernia, Hiatal 1 Gastroesophageal Reflux 1 Esophageal Neoplasms 1 Esophageal Diseases 1 Esophageal Achalasia 1 Craniopharyngioma 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1 Breast Cancer Female 1 Adenocarcinoma 1

Interventions

aldesleukin 43 Sunitinib 42 Cyclophosphamide 30 Nivolumab 29 pembrolizumab 27 Everolimus 27 Interferon-alpha 25 Bevacizumab 23 Sorafenib 22 Interleukin-2 20 fludarabine phosphate 19 Radiotherapy 18 Ipilimumab 18 Filgrastim 18 Axitinib 18 Gene Expression Profiling 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 cabozantinib 14 Radiosurgery 13 fludarabine 11 Doxorubicin 11 Carboplatin 11 Blood Specimen Collection 11 temsirolimus 10 atezolizumab 9 Immunohistochemistry 9 Etoposide 9 Chemotherapy, Adjuvant 9 sargramostim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × Tumor Burden × Clear all

NCT04005820 2019-07-02

UMBRELLA

Assistance Publique Hopitaux De Marseille

Phase NA Not yet recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡